HealthEquity demonstrates a robust and defensible business model anchored in the growing HSA market, with strong legislative tailwinds expanding its addressable market. The company's integration of AI and mobile technologies supports operational efficiency and member engagement, reinforcing competi…
HealthEquity (HQY) Q2 2026: 9% Revenue Growth Amid Record Margin Expansion and Legislative Tailwinds
HealthEquity delivered robust top-line growth and margin expansion despite a challenging macro environment, fueled by legislative expansions and operational efficiencies. The company is strategically investing in AI-driven automation and enhanced mobile experiences to drive member engagement and cost control. Legislative changes unlocking millions of new HSA-eligible consumers position HealthEquity for accelerated growth in coming quarters.
Summary
- Legislative Expansion Unlocks Market: Largest HSA eligibility expansion in two decades broadens addressable market significantly.
- Operational Efficiency Drives Margin Gains: AI-powered automation and mobile adoption reduce service costs while improving member satisfaction.
- Strategic Growth Investments Ahead: Enhanced onboarding and marketing efforts target new ACA bronze plan enrollees and SMB employers.
Business Overview
HealthEquity is the largest custodian of Health Savings Accounts (HSAs) in the U.S., providing a platform that enables consumers to save, spend, and invest tax-advantaged funds for healthcare expenses. The company generates revenue primarily through service fees, custodial fees on client-held assets, and interchange fees from payment transactions. Its business segments include HSA accounts, complementary consumer-directed benefits (CDBs), and investment services linked to these accounts.
Performance Analysis
In the second quarter of fiscal 2026, HealthEquity reported 9% year-over-year revenue growth to $325.8 million, driven by a 15% increase in custodial revenue and 8% growth in interchange revenue. Service revenue grew modestly by 1%, reflecting steady fee-based income from account administration. The company achieved record gross margins of 71%, up from 68% a year ago, supported by declining service costs and fraud-related expense improvements.
Adjusted EBITDA rose 18% to $151.1 million, representing a near-record 46% margin. Net income surged 67% to $59.9 million, reflecting operational leverage and lower fraud costs. HSA accounts increased 6% to nearly 10 million, while total accounts including CDBs grew 5% to 17.1 million. Total HSA assets expanded 12% to $33.1 billion, with invested assets growing 23% to $16.1 billion, signaling deeper member engagement.
- Margin Expansion from Cost Control and Fraud Reduction: Service costs declined year-over-year aided by AI-driven claims automation and enhanced fraud prevention.
- Account Growth Resilient Despite Soft Labor Market: New HSAs from sales totaled 163,000, reflecting strong enterprise wins and retention amid macro headwinds.
- Investment Assets as Engagement Indicator: The 10% increase in HSA members with investments underscores success in driving higher-value member relationships.
Overall, HealthEquity’s results demonstrate a balanced growth model combining account expansion, deeper member engagement, and disciplined expense management, positioning the company well for sustained profitability.
Executive Commentary
"The HealthEquity team delivered continued momentum during our second quarter with strong 9% revenue growth, record gross margin of 71% and record adjusted EBITDA of $151 million."
Scott Cutler, President and CEO
"Our fiscal 26 guidance reflects the expected carry forward of the trajectories for revenue and margins the remainder of this year, including increased technology and security investments as we enhance our member-first secure mobile experience and improve the member experience."
James Lucania, Executive Vice President and CFO
Strategic Positioning
1. Legislative Expansion Catalyzing Market Growth
The July budget bill enacted the largest expansion of HSA eligibility in 20 years, allowing direct primary care and low-cost telehealth services before deductibles are met, and enabling individuals with ACA bronze and catastrophic plans to open HSAs starting January 2026. This unlocks access for an estimated 3 to 4 million additional households. HealthEquity is actively preparing its enrollment and onboarding platforms to capitalize on this expanded addressable market.
2. AI and Automation Driving Operational Efficiency
HealthEquity has integrated AI technologies such as expedited claims adjudication and agentic AI in voice channels to automate manual processes in service delivery. These initiatives have already contributed to reduced service costs, improved member satisfaction, and a 9% reduction in headcount year-over-year. The company anticipates further cost savings and enhanced member engagement as AI capabilities expand.
3. Mobile-First Member Experience as a Competitive Advantage
The company’s secure mobile app, downloaded by 1.7 million members, is central to its strategy to improve member engagement and fraud prevention. The rollout of Passkey authentication enhances security and streamlines access, supporting the goal of normalizing fraud costs to one basis point of total HSA assets annually. Mobile adoption aligns with HealthEquity’s mission to empower consumers to save, spend, and invest more effectively.
4. Focused Marketing and Product Innovation Targeting SMBs and ACA Enrollees
HealthEquity is investing in marketing campaigns and enhanced enrollment experiences to capture new HSA-eligible consumers under ACA bronze plans and small-to-medium business (SMB) employers adopting HSA-qualified health plans. The Analyzer tool provides data-driven plan design recommendations, helping employers manage healthcare cost growth while increasing HSA adoption rates among employees.
5. Interest Rate Hedging to Stabilize Yield on HSA Cash
The company entered $1.2 billion of Treasury bond forward contracts locking an average five-year Treasury yield just over 4%, mitigating interest rate volatility on future HSA cash placements. This de-risking strategy supports stable custodial revenue amid fluctuating market rates, with an expected average HSA cash yield of approximately 3.5% for fiscal 2026.
Key Considerations
HealthEquity’s Q2 results reflect a strategic balance of growth and efficiency in a complex macro environment. Key points for investors include:
- Legislative Tailwind: The expanded HSA eligibility via the budget bill significantly enlarges the potential customer base, offering a multi-year growth runway.
- Operational Leverage: AI-driven automation and mobile app adoption are materially reducing service costs and fraud expenses, enhancing margins.
- Member Engagement Focus: Growth in invested assets and active mobile users signals deeper engagement, which correlates with higher contribution and retention rates.
- Market Growth Amid Macro Challenges: Despite slower labor market growth, HealthEquity’s enterprise sales pipeline and retention efforts are offsetting headwinds.
- Capital Allocation Discipline: The company continues share repurchases and debt reduction, balancing growth investments with shareholder returns and financial flexibility.
Risks
Potential risks include continued macroeconomic softness impacting employer hiring and new account growth, regulatory changes affecting HSA eligibility or tax treatment, and cybersecurity threats despite ongoing fraud prevention efforts. Interest rate fluctuations remain a factor despite hedging, and execution risks exist around scaling new enrollment experiences and marketing initiatives.
Forward Outlook
For fiscal 2026, HealthEquity expects:
- Revenue between $1.29 billion and $1.31 billion
- GAAP net income of $185 million to $200 million ($2.11 to $2.28 per diluted share)
- Non-GAAP net income of $329 million to $344 million ($3.74 to $3.91 per diluted share)
- Adjusted EBITDA between $540 million and $560 million
Management plans to continue investing in technology, security, and marketing to support the expanded HSA market, while normalizing fraud costs and executing share repurchases. The company also anticipates stable yields on HSA cash placements supported by interest rate hedging.
Takeaways
HealthEquity’s second quarter performance underscores its leadership in the HSA market and its ability to navigate a challenging macroeconomic landscape through strategic innovation and legislative tailwinds.
- Robust Growth Engine: Legislative changes and strong enterprise sales pipeline are expanding the addressable market and fueling account growth despite labor market softness.
- Operational Excellence: AI-driven automation and enhanced mobile experience are driving margin expansion and reducing fraud-related costs.
- Execution Focus: Ongoing investments in marketing and onboarding technology position HealthEquity to capitalize on new ACA bronze plan enrollees and SMB opportunities.
Conclusion
HealthEquity demonstrated strong revenue and margin growth in Q2 2026, supported by significant legislative expansions and operational efficiencies. The company’s strategic investments in AI, mobile, and marketing, combined with disciplined capital allocation, set a solid foundation for continued growth and profitability in a dynamic healthcare benefits landscape.
Industry Read-Through
HealthEquity’s results highlight the growing importance of consumer-directed health accounts in managing rising healthcare costs. The legislative expansion of HSA eligibility signals a broader industry shift towards tax-advantaged health savings vehicles, likely prompting competitors to enhance digital engagement and operational efficiency. The company’s successful integration of AI and mobile-first strategies may serve as a benchmark for peers aiming to improve member experience and reduce service costs in the evolving benefits administration sector.